Martindale updated with 78 revised and 92 new monographs, plus 8 revised chapters or chapter sections.
This quarter, revision has been carried out on Anthelmintics, Antimalarials, General Anaesthetics, Growth Hormone and its Modulators, and also on sections of Antidiabetics, Cardiovascular Drugs, Chelators Antidotes and Antagonists, and Pharmaceutical Excipients.
In addition, 92 new monographs have been added and a further 78 existing monographs and treatment reviews have been updated. Precautions for Porphyria have been updated throughout the publication and Chinese, Greek and Japanese synonyms have also been added. Information on drugs restricted in sport has been updated for the WADA Prohibited List 2012.
Preparations have been updated for 12 countries.
Full details (PDF).
Martindale updated with 56 revised and 34 new monographs, plus 9 revised chapters or chapter sections.
This quarter, revision has been carried out on Antimigraine Drugs, Thyroid and Antithyroid Drugs, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antibacterials, Antineoplastics, Antivirals, Anxiolytic Sedatives Hypnotics and Antipsychotics, Chelators Antidotes and Antagonists, and Pharmaceutical Excipients.
In addition, 34 new monographs have been added and a further 56 existing monographs and treatment reviews have been updated. Further UNII codes have also been added to monographs. Pharmacopoeial information in monographs throughout the publication has also been updated to reflect the PhEur 7.3 and the USP 34 and USNF 29 (including supplement 2).
Preparations have been updated for 9 countries.
Full details (PDF).
Martindale updated with 62 revised and 34 new monographs, plus 14 revised chapters or chapter sections.
This quarter, revision has been carried out on Antimyasthenics and Obstetric Drugs, and also on sections of Antibacterials, Antidiabetics, Antineoplastics, Antivirals, Anxiolytics, Cardiovascular Drugs, and Chelators Antidotes and Antagonists.
In addition, 34 new monographs have been added and a further 62 existing monographs and treatment reviews have been updated. More UNII codes have also been added to monographs. Pharmacopoeial information in monographs throughout the publication has also been updated to reflect the PhEur 7.2 and the USP 34 and USNF 29 (including supplement 1).
Preparations have been updated for 10 countries.
For this update, we have introduced the first tranche of Japanese synonyms.
Full details (PDF).
Martindale updated with 45 revised and 16 new monographs, plus 12 revised chapters or chapter sections.
This quarter, revision has been carried out on Antigout Drugs, Antiprotozoals and Radiopharmaceuticals, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antibacterials, Anxiolytics, and Cardiovascular Drugs.
In addition, 16 new monographs have been added and a further 45 existing monographs and treatment reviews have been updated. More UNII codes have been added to monographs and the ATC and ATC(Vet) codes have updated. Pharmacopoeial information in monographs throughout the publication has also been updated to reflect the PhEur 7.1, BP 2011, BP(Vet) 2011, and updates in the 2nd supplement to the USP 33 and USNF 28.
Preparations have been updated for 8 countries.
For this update, we have introduced the first tranche of INNs in Arabic and in Chinese.
Full details (PDF).
Martindale updated with 26 new monographs, plus a new chapter section containing an additional 81 substances
This quarter, a new chapter section on `Additional Substances of Medical Interest' has been compiled of 81 substances that appear on the WADA Prohibited List and which do not appear elsewhere in Martindale.
In addition 21 other new monographs have been added to existing chapter sections and a further 53 monographs and treatment reviews have been updated. More UNII codes have been added to monographs and information on drugs restricted in sport has been updated for the WADA Prohibited List 2011. Pharmacopoeial information has also been updated to reflect the PhEur 7.0 in monographs throughout the publications.
Preparations have been updated for 7 countries
Full details (PDF).
Martindale updated with 30 new monographs, plus 26 revised chapters or chapter sections
This quarter, revision has been carried out on Antidepressants, Blood Products Plasma Expanders and Haemostatics, Corticosteroids, Dermatological Drugs and Sunscreens, Disinfectants and Preservatives, General Anaesthetics, Local Anaesthetics, Miotics Mydriatics and Antiglaucoma Drugs, Muscle Relaxants, Neuromuscular Blockers, Pesticides and Repellents, Sex Hormones and their Modulators, and Vaccines Immunoglobulins and Antisera, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Cardiovascular Drugs, and Supplementary Drugs and Other Substances.
In addition, 30 new monographs and treatment reviews have been added.
Preparations have been updated for 5 countries.
Full details (PDF).
For this update, we have introduced an additional drug coding system: UNII (Unique Ingredient Identifier) codes, produced by the FDA as part of the FDA/USP Substance Registration System. These codes are intended to provide a unique and unambiguous identifier for substances in drugs, biologics, foods, and devices.
Martindale updated with 13 revised and 39 new monographs, plus 11 revised chapters or chapter sections
This quarter, revision has been carried out on Antifungals, Chelators Antidotes and Antagonists, Gases, Immunosuppressants, and Stimulants and Anorectics, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antibacterials, Antineoplastics, Antivirals, Cardiovascular Drugs, and Supplementary Drugs and Other Substances.
In addition, 39 new monographs and treatment reviews have been added and a further 13 existing monographs and treatment reviews have been updated.
Preparations have been updated for 10 countries.
Full details (PDF).
For this update, we have introduced 2 additional drug coding systems: ATC codes for herbal medicines now complement the existing ATC codes for conventional and veterinary drugs; and Martindale's own unique identifiers, the Martindale codes.
The display of modification dates has been extended to most documents in Martindale. In the drug monographs, each major section now carries the date at which a change was last made. This is in addition to the revision dates currently displayed at the top of the monographs. Modification dates are also displayed in treatment reviews, preparations, and manufacturers records.
Another enhancement is to the way results are delivered when the search results are limited using the Sections or Interactions tabs. Rather than presenting the information within the full monograph, just the section requested is displayed. This should help to give a more focussed result and shorten document displays. Links to the complete monograph and to other sections are presented at the top of the document. Please let us know if you find this new presentation useful by using the Feedback form.
Martindale updated with 7 revised and 41 new monographs, plus 30 revised chapters or chapter sections
This quarter, revision has been carried out on Anthelmintics, Antiepileptics, Antihistamines, Antimalarials, Antiparkinsonian Drugs, Cough Suppressants Expectorants Mucolytics and Nasal Decongestants, Obstetric Drugs, Radiopharmaceuticals, and Stimulants and Anorectics, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antineoplastics, Antivirals, Cardiovascular Drugs, Pharmaceutical Excipients, Sex Hormones and their Modulators, and Supplementary Drugs and Other Substances.
In addition, 41 new monographs and treatment reviews have been added and a further 7 existing monographs and treatment reviews have been updated. Information on drugs in the Japanese Pharmacopoeia, 15th edition, ATC codes for veterinary drugs, and street names has been updated.
Preparations have also been updated for 7 countries.
Full details (PDF).
Martindale updated with 18 revised and 48 new monographs, plus 43 revised chapters or chapter sections
This quarter, revision has been carried out on Antidiabetics and also on sections of Antibacterials, Antineoplastics, Anxiolytic Sedatives Hypnotics and Antipsychotics, Bronchodilators and Anti-Asthma Drugs, Cardiovascular Drugs, Gastrointestinal Drugs, Pharmaceutical Excipients, and Supplementary Drugs and Other Substances.
In addition, 48 new monographs have been added and a further 18 existing monographs and treatment reviews have been updated. Information on drugs restricted in sport has been updated for the WADA Prohibited List 2010.
Preparations have also been updated for 6 countries.
Full details (PDF).
Martindale updated with 22 revised and 10 new monographs, plus 27 revised chapters or chapter sections
This quarter, revision has been carried out on Antiprotozoals, Contrast Media, Electrolytes, and Gases, and also on sections of Antibacterials, Antineoplastics, Anxiolytic Sedatives Hypnotics and Antipsychotics, Cardiovascular Drugs, Gastrointestinal Drugs, Pharmaceutical Excipients, and Supplementary Drugs and Other Substances.
In addition, 10 new monographs have been added and a further 22 existing monographs and treatment reviews have been updated.
Preparations have also been updated for 8 countries.
Full details (PDF).
Martindale updated with 15 revised and 13 new monographs, plus 8 revised chapters or chapter sections
This quarter, revision has been carried out on Antimigraine Drugs, Bone Modulating Drugs, Growth Hormone and its Modulators, Nutritional Agents and Vitamins, and Thyroid and Antithyroid Drugs and also on sections of Antibacterials, Anxiolytic Sedatives Hypnotics and Antipsychotics, and Cardiovascular Drugs.
In addition, 13 new monographs have been added and a further 15 existing monographs and treatment reviews have been updated.
A new index entitled Pharmaceutical Terms in Various Languages has been included. It lists some of the commoner pharmaceutical forms and routes in English and a number of major European languages.
Preparations have also been updated for 9 countries.
Full details (PDF).
Martindale updated with 14 revised and 9 new monographs, plus 6 chapters revised fully or in part, and updated product information for 9 countries.
This quarter, complete revision and revalidation has been carried out on Antidementia Drugs, Antigout Drugs, Antimyasthenics, and Urological Drugs, and also selected treatment reviews from Antibacterials and Cardiovascular Drugs. In addition, 9 new monographs have been added and a further 14 existing monographs and treatment reviews have been updated.
Preparations have also been updated for 9 countries.
Full details (PDF).
Martindale updated with 22 revised and 12 new monographs, plus one fully revised chapter section, and updated product information for 10 countries.
This quarter, complete revision and revalidation of the information on Glycopeptide Antibacterials has been completed. A new chapter on Pharmaceutical Excipients has been created comprising relevant monographs from other existing chapters. In addition, 12 new monographs have been added and a further 22 existing monographs and treatment reviews have been updated.
Preparations have also been updated for 10 countries.
Full details (PDF).
This quarter, 68 new monographs have been added and a further 11 have been updated, in addition to the completion of revision and revalidation of the complete database. A new feature allows easier identification of preparations with similar ingredients.
This quarter, revision and revalidation of the information on all chapters has been completed. In addition, 68 new monographs have been added and a further 11 existing monographs and treatment reviews have been updated.
Preparations have been updated for 6 countries.
A new feature added this quarter means that it is easier to identify multi-ingredient preparations with similar ingredients. The list of other preparations appears at the bottom of any multi-ingredient preparation record.
Full details (PDF).
Martindale updated with 19 revised and 30 new monographs, plus 3 fully revised chapters, and updated product information for 8 countries.
This quarter, complete revision and revalidation of the information on Allergen Products, Angina Pectoris, Bronchodilators and Anti-asthma Drugs (complete chapter), Glatiramer Acetate, Glicofosfopeptical, Hypertension, Immunosuppressants (complete chapter), Myocardial Infarction, Nonionic Surfactants (complete chapter), Pneumonia, Reperfusion and Revascularisation, Thalidomide, and Valvular Heart Disease has been completed. In addition, 30 new monographs have been added and a further 9 existing monographs and treatment reviews have been updated.
Preparations have been updated for 8 countries including Indonesia which is new for this quarter.
Full details (PDF).
Martindale updated with 50 revised and 45 new monographs, plus 4 fully revised chapter sections, and updated product information for 6 countries.
This quarter, 45 new monographs have been added and 50 existing monographs and treatment reviews have been updated, plus complete revision and revalidation of the information on miscellaneous Antibacterials, Beta Blockers, Hormonal Contraceptives and Hormone Replacement Therapy, and some Biologicals. Preparations have also been updated for 6 countries.
Full details (PDF).
Martindale updated with 66 revised and 28 new monographs, including 5 fully revised chapters, and product information updated for 10 countries
This quarter, 28 new monographs have been added and 66 existing monographs and treatment reviews have been updated, including complete revision and revalidation of the information on Androgens and Anabolics, Antimycobacterials, Dermatological Drugs and Sunscreens, Nonsteroidal Anti-inflammatory Drugs, and Paraffins and Similar Bases. Preparations have also been updated for 10 countries.
We have added an alphabetical list of disease treatment reviews to the table of contents to make them easier to find.
Full details (PDF).
MedicinesComplete User Survey - RPS Publishing is seeking important input from their customers
Martindale updated with 105 revised and 19 new monographs, including 2 fully revised chapters, and product information updated for 9 countries
This quarter, 19 new monographs have been added and 105 existing monographs and treatment reviews have been updated, including complete revision and revalidation of the information on lincosamides in the chapter on Antibacterials and antiarrythmics in the chapter on Cardiovascular Drugs. Preparations have also been updated for 9 countries, including the Philippines and Poland, both new for this quarter.
Full details (PDF).
Revised chapters, monographs, and product information
This quarter, 6 chapters or chapter sections have been completely revised and revalidated, 31 new monographs have been added, and 55 existing monographs and treatment reviews have been updated. Preparations have also been updated for 6 countries.
Drug monographs are now listed alphabetically in the contents list under Drugs and Ancillary Substances as well as by therapeutic use.
Full details (PDF).
Revised chapters, monographs, and product information
This quarter, 5 chapters or chapter sections have been completely revised and revalidated, 21 new monographs have been added, and 40 existing monographs and treatment reviews have been updated. Preparations have also been updated for 8 countries.
Chapters on Prostaglandins and Hypothalamics have been reorganised and their contents added to new chapters on Obstetric Drugs and Growth Hormone and its Modulators.
A new printable User's Guide is now available to download from the Martindale home page.
Full details (PDF).
Revised chapters, monographs, and product information
This quarter, information on miscellaneous analgesics, anti-inflammatory drugs, and antipyretics has been completely revised and revalidated, 63 new monographs have been added, and 76 existing monographs and treatment reviews have been updated. Preparations and manufacturer information from 12 countries has been updated, including Turkey, new for this quarter.
Full details (PDF).
Revised chapters, monographs, and product information
This quarter, 46 chapters have been revised, 72 new monographs have been added, 1 new treatment review has been added, and a further 4 monographs have been updated.
Full details (PDF).
Revised chapters, monographs, and product information
This quarter, eight chapters have been completely revised and revalidated, 10 new monographs have been added, 3 new treatment reviews have been added, and a further 6 monographs have been updated.
Full details (PDF).
Martindale updated with new and revised monographs and new product information
This quarter, eight chapters or chapter sections have been completely revised and revalidated, 19 new monographs have been added, 3 new treatment reviews have been added, 1 new country has been added and preparations for a further 7 countries have been updated, and 31 monographs have been updated.
Full details (PDF).
Martindale updated with new and revised monographs and new product information
This quarter, five chapters have been completely revised and revalidated, 39 new monographs and 7 new treatment reviews have been added, and a further 80 monographs have been updated. Preparations have been updated for 9 countries. In addition, pharmacopoeial information has been updated to reflect the BP 2005, USP 29, USNF 24, PhEur 5.4, and Ger.P. 2005 in monographs throughout the publication.
Full details (PDF).
New and revised information, and more international names now available in Martindale
This quarter, one chapter has been completely revised and revalidated, 13 new monographs have been added, and a further 67 monographs have been updated. We have also added structural formulae to many monographs and now include the International Nonproprietary Names in Spanish, French, Russian, and Latin as well as English. ATC codes have been added to the table of contents to give another way to find information.
Full details (PDF).
Revised chapters, monographs, and product information
The June update contains 2 completely re-evaluated chapters, 11 new drug monographs, updates to a further 97 drug and treatment monographs, and updated proprietary product information for 9 countries.
Full details (PDF).
Revised chapters, monographs and product information.
The March update contains 2 completely re-evaluated chapters, 19 new drug monographs, updates to a further 74 drug and treatment monographs, and updated proprietary product information for 10 countries.